March 17, 2020 / 10:06 AM / 18 days ago

BRIEF-Shield Therapeutics Says Feraccru/Accrufer Approved For Treatment Of Iron Deficiency In Adults

March 17 (Reuters) - Shield Therapeutics PLC:

* SHIELD THERAPEUTICS PLC - FERACCRU/ACCRUFER APPROVED FOR TREATMENT OF IRON DEFICIENCY IN ADULTS WITH OR WITHOUT ANAEMIA IN USA, EU & SWITZERLAND

* SHIELD THERAPEUTICS - IN STUDY, FERACCRU/ACCRUFER CLEARLY DEMONSTRATED EFFECTIVENESS, BUT DID NOT ACHIEVE NON-INFERIORITY COMPARED TO IV IRON THERAPY

* SHIELD THERAPEUTICS PLC - BOARD HAS INSTIGATED AN IMMEDIATE INDEPENDENT REVIEW INTO ANALYSIS OF DATASETS RELATING TO STUDY OF FERACCRU/ACCRUFER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below